Cargando…

Gullo’s syndrome – what do we know?

Benign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. G...

Descripción completa

Detalles Bibliográficos
Autores principales: Rycyk, Anna, Furtak, Paulina, Mądro, Agnieszka, Kasztelan-Szczerbińska, Beata, Cichoż-Lach, Halina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456765/
https://www.ncbi.nlm.nih.gov/pubmed/34584577
http://dx.doi.org/10.5114/pg.2020.101133
Descripción
Sumario:Benign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. Gullo’s syndrome is a diagnosis of exclusion, and clinicians should be aware of various other conditions which can cause elevation of pancreatic enzymes. However, the diagnostic pathway should be done with the right accuracy to avoid unnecessary examinations.